Periodic Reporting for period 1 - RNhale (Dry Powder Formulation of RNA Nanoparticles for Inhalation and Improved Storage and Transport Conditions)

While existing RNA drugs primarily target the liver, the lung presents a variety of currently untargeted diseases for RNA therapeutics. By employing local pulmonary delivery of RNA nanoparticles, there is potential to expand drug delivery beyond the liver. Utilizing dry powder...